Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Cash from Financing Activities (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Cash from Financing Activities for 16 consecutive years, with $13.5 million as the latest value for Q1 2026.

  • Quarterly Cash from Financing Activities fell 41.33% to $13.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$40.6 million through Jan 2026, down 525.03% year-over-year, with the annual reading at -$40.6 million for FY2026, 525.03% down from the prior year.
  • Cash from Financing Activities for Q1 2026 was $13.5 million at Usana Health Sciences, up from -$979000.0 in the prior quarter.
  • The five-year high for Cash from Financing Activities was $22.9 million in Q4 2024, with the low at -$122.4 million in Q1 2022.
  • Average Cash from Financing Activities over 5 years is -$11.6 million, with a median of -$1.4 million recorded in 2024.
  • The sharpest move saw Cash from Financing Activities plummeted 26356.82% in 2023, then surged 3384.8% in 2024.
  • Over 5 years, Cash from Financing Activities stood at -$150000.0 in 2022, then surged by 538.67% to $658000.0 in 2023, then soared by 3384.8% to $22.9 million in 2024, then plummeted by 104.27% to -$979000.0 in 2025, then soared by 1474.16% to $13.5 million in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at $13.5 million, -$979000.0, and -$38.6 million for Q1 2026, Q3 2025, and Q2 2025 respectively.